Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer
Completed · Phase 2
Conditions studied: Recurrent or Metastatic Breast Cancer
In brief
The objective of this study is to evaluate the efficacy, safety and pharmacokinetics of DHP107 (Oral Paclitaxel, Korea brand name: Liporaxel®) compared to IV Paclitaxel in patients with Recurrent or Metastatic Breast Cancer.
Key facts
- Study ID
- NCT03326102
- Run by
- Daehwa Pharmaceutical Co., Ltd.
- People needed
- 72
- Starts
- 2018-07-06
- Expected to finish
- 2022-12-13
- Last updated by the study team
- 2024-02-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- California Research Institute (CRI) — Los Angeles, California, United States
- University of California San Francisco (UCSF) — San Francisco, California, United States
- Boca Raton Regional Hospital (BRRH) — Boca Raton, Florida, United States
- ASCLEPES Research Center(ARC) — Weeki Wachee, Florida, United States
- Saint Luke's Cancer Institute(SLCI) — Kansas City, Kansas, United States
- University of Kansas Medical Center(KUMC) — Kansas City, Kansas, United States
- Anne Arundel Health System Research Institute (AAHS) — Annapolis, Maryland, United States
- Massachusetts General Hospital(MGH) — Boston, Massachusetts, United States
- Michigan Center of Medical Research(MCMR) — Farmington Hills, Michigan, United States
- Metro-Minnesota Community Oncology Research Consortium (MMCORC) — Minneapolis, Minnesota, United States
- Nevada Cancer Research Foundation (NCRF) — Las Vegas, Nevada, United States
- University of Pittsburgh Medical Center (UPMC) — Pittsburgh, Pennsylvania, United States
- Onkologicka klinika, Fakultni nemocnice Olomouc (OUH) — Olomouc, I.P. Pavlova 6, Czechia
- Onkologicky stacionar, NH Hospital a.s., nemocnice Horovice (NHH) — Hořovice, K Nemocnici, Czechia
- Onkologicka klinika, Vseobecna fakultni nemocnice v Praze (VFN) — Prague, U Nemocnice 499/2, Czechia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.